nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobetasol propionate—Skin striae—Bleomycin—testicular cancer	0.0485	0.0485	CcSEcCtD
Clobetasol propionate—Skin hypertrophy—Bleomycin—testicular cancer	0.0406	0.0406	CcSEcCtD
Clobetasol propionate—Telangiectasia—Methotrexate—testicular cancer	0.0265	0.0265	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Bleomycin—testicular cancer	0.026	0.026	CcSEcCtD
Clobetasol propionate—Eruption—Dactinomycin—testicular cancer	0.0234	0.0234	CcSEcCtD
Clobetasol propionate—Folliculitis—Dactinomycin—testicular cancer	0.0229	0.0229	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Ifosfamide—testicular cancer	0.0222	0.0222	CcSEcCtD
Clobetasol propionate—Secondary infection—Epirubicin—testicular cancer	0.0199	0.0199	CcSEcCtD
Clobetasol propionate—Delusion—Ifosfamide—testicular cancer	0.0186	0.0186	CcSEcCtD
Clobetasol propionate—Secondary infection—Doxorubicin—testicular cancer	0.0184	0.0184	CcSEcCtD
Clobetasol propionate—Tenderness—Bleomycin—testicular cancer	0.0177	0.0177	CcSEcCtD
Clobetasol propionate—Eye irritation—Ifosfamide—testicular cancer	0.0154	0.0154	CcSEcCtD
Clobetasol propionate—Tenderness—Ifosfamide—testicular cancer	0.0151	0.0151	CcSEcCtD
Clobetasol propionate—Leukoderma—Methotrexate—testicular cancer	0.0147	0.0147	CcSEcCtD
Clobetasol propionate—Infection—Carboplatin—testicular cancer	0.0137	0.0137	CcSEcCtD
Clobetasol propionate—Leukoderma—Epirubicin—testicular cancer	0.0137	0.0137	CcSEcCtD
Clobetasol propionate—Tenderness—Cisplatin—testicular cancer	0.013	0.013	CcSEcCtD
Clobetasol propionate—Tingling sensation—Etoposide—testicular cancer	0.013	0.013	CcSEcCtD
Clobetasol propionate—Leukoderma—Doxorubicin—testicular cancer	0.0127	0.0127	CcSEcCtD
Clobetasol propionate—Pain—Carboplatin—testicular cancer	0.0118	0.0118	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Methotrexate—testicular cancer	0.0105	0.0105	CcSEcCtD
Clobetasol propionate—Eruption—Methotrexate—testicular cancer	0.0101	0.0101	CcSEcCtD
Clobetasol propionate—Psoriasis—Methotrexate—testicular cancer	0.00993	0.00993	CcSEcCtD
Clobetasol propionate—Folliculitis—Methotrexate—testicular cancer	0.00993	0.00993	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Epirubicin—testicular cancer	0.00982	0.00982	CcSEcCtD
Clobetasol propionate—Pain in extremity—Ifosfamide—testicular cancer	0.00958	0.00958	CcSEcCtD
Clobetasol propionate—Eruption—Epirubicin—testicular cancer	0.00949	0.00949	CcSEcCtD
Clobetasol propionate—Folliculitis—Epirubicin—testicular cancer	0.00929	0.00929	CcSEcCtD
Clobetasol propionate—Psoriasis—Epirubicin—testicular cancer	0.00929	0.00929	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Vinblastine—testicular cancer	0.00913	0.00913	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Doxorubicin—testicular cancer	0.00909	0.00909	CcSEcCtD
Clobetasol propionate—Alopecia—Chlorambucil—testicular cancer	0.00885	0.00885	CcSEcCtD
Clobetasol propionate—Eruption—Doxorubicin—testicular cancer	0.00879	0.00879	CcSEcCtD
Clobetasol propionate—Psoriasis—Doxorubicin—testicular cancer	0.0086	0.0086	CcSEcCtD
Clobetasol propionate—Folliculitis—Doxorubicin—testicular cancer	0.0086	0.0086	CcSEcCtD
Clobetasol propionate—Alopecia—Vinblastine—testicular cancer	0.00811	0.00811	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Bleomycin—testicular cancer	0.00771	0.00771	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Ifosfamide—testicular cancer	0.00747	0.00747	CcSEcCtD
Clobetasol propionate—Rash pustular—Epirubicin—testicular cancer	0.00732	0.00732	CcSEcCtD
Clobetasol propionate—Glycosuria—Epirubicin—testicular cancer	0.00721	0.00721	CcSEcCtD
Clobetasol propionate—Stinging—Epirubicin—testicular cancer	0.00721	0.00721	CcSEcCtD
Clobetasol propionate—Infection—Chlorambucil—testicular cancer	0.00707	0.00707	CcSEcCtD
Clobetasol propionate—Alopecia—Bleomycin—testicular cancer	0.00685	0.00685	CcSEcCtD
Clobetasol propionate—Rash pustular—Doxorubicin—testicular cancer	0.00678	0.00678	CcSEcCtD
Clobetasol propionate—Erythema—Bleomycin—testicular cancer	0.00675	0.00675	CcSEcCtD
Clobetasol propionate—Stinging—Doxorubicin—testicular cancer	0.00667	0.00667	CcSEcCtD
Clobetasol propionate—Glycosuria—Doxorubicin—testicular cancer	0.00667	0.00667	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Ifosfamide—testicular cancer	0.00651	0.00651	CcSEcCtD
Clobetasol propionate—Alopecia—Dactinomycin—testicular cancer	0.00639	0.00639	CcSEcCtD
Clobetasol propionate—Erythema—Dactinomycin—testicular cancer	0.00629	0.00629	CcSEcCtD
Clobetasol propionate—Pain—Chlorambucil—testicular cancer	0.00608	0.00608	CcSEcCtD
Clobetasol propionate—Paraesthesia—Vinblastine—testicular cancer	0.00585	0.00585	CcSEcCtD
Clobetasol propionate—Alopecia—Ifosfamide—testicular cancer	0.00585	0.00585	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Epirubicin—testicular cancer	0.00577	0.00577	CcSEcCtD
Clobetasol propionate—Erythema—Ifosfamide—testicular cancer	0.00577	0.00577	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Cisplatin—testicular cancer	0.00561	0.00561	CcSEcCtD
Clobetasol propionate—Pain—Vinblastine—testicular cancer	0.00558	0.00558	CcSEcCtD
Clobetasol propionate—Infection—Bleomycin—testicular cancer	0.00547	0.00547	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Doxorubicin—testicular cancer	0.00534	0.00534	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Chlorambucil—testicular cancer	0.00524	0.00524	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Etoposide—testicular cancer	0.00521	0.00521	CcSEcCtD
Clobetasol propionate—Infection—Dactinomycin—testicular cancer	0.0051	0.0051	CcSEcCtD
Clobetasol propionate—Alopecia—Cisplatin—testicular cancer	0.00505	0.00505	CcSEcCtD
Clobetasol propionate—Pruritus—Chlorambucil—testicular cancer	0.00503	0.00503	CcSEcCtD
Clobetasol propionate—Erythema—Cisplatin—testicular cancer	0.00497	0.00497	CcSEcCtD
Clobetasol propionate—Paraesthesia—Bleomycin—testicular cancer	0.00494	0.00494	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00488	0.00488	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Vinblastine—testicular cancer	0.0048	0.0048	CcSEcCtD
Clobetasol propionate—Vascular purpura—Epirubicin—testicular cancer	0.00474	0.00474	CcSEcCtD
Clobetasol propionate—Pain—Bleomycin—testicular cancer	0.00471	0.00471	CcSEcCtD
Clobetasol propionate—Infection—Ifosfamide—testicular cancer	0.00468	0.00468	CcSEcCtD
Clobetasol propionate—Alopecia—Etoposide—testicular cancer	0.00462	0.00462	CcSEcCtD
Clobetasol propionate—Skin disorder—Ifosfamide—testicular cancer	0.00457	0.00457	CcSEcCtD
Clobetasol propionate—Purpura—Epirubicin—testicular cancer	0.0044	0.0044	CcSEcCtD
Clobetasol propionate—Pain—Dactinomycin—testicular cancer	0.00439	0.00439	CcSEcCtD
Clobetasol propionate—Vascular purpura—Doxorubicin—testicular cancer	0.00438	0.00438	CcSEcCtD
Clobetasol propionate—Pain in extremity—Epirubicin—testicular cancer	0.00424	0.00424	CcSEcCtD
Clobetasol propionate—Paraesthesia—Ifosfamide—testicular cancer	0.00423	0.00423	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.0042	0.0042	CcSEcCtD
Clobetasol propionate—Headache—Vinblastine—testicular cancer	0.00408	0.00408	CcSEcCtD
Clobetasol propionate—Purpura—Doxorubicin—testicular cancer	0.00407	0.00407	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Bleomycin—testicular cancer	0.00406	0.00406	CcSEcCtD
Clobetasol propionate—Infection—Cisplatin—testicular cancer	0.00403	0.00403	CcSEcCtD
Clobetasol propionate—Pain—Ifosfamide—testicular cancer	0.00402	0.00402	CcSEcCtD
Clobetasol propionate—Skin disorder—Cisplatin—testicular cancer	0.00394	0.00394	CcSEcCtD
Clobetasol propionate—Pain in extremity—Doxorubicin—testicular cancer	0.00392	0.00392	CcSEcCtD
Clobetasol propionate—Pruritus—Bleomycin—testicular cancer	0.0039	0.0039	CcSEcCtD
Clobetasol propionate—Dry skin—Epirubicin—testicular cancer	0.00389	0.00389	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00385	0.00385	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Dactinomycin—testicular cancer	0.00378	0.00378	CcSEcCtD
Clobetasol propionate—Infection—Etoposide—testicular cancer	0.00369	0.00369	CcSEcCtD
Clobetasol propionate—Paraesthesia—Cisplatin—testicular cancer	0.00364	0.00364	CcSEcCtD
Clobetasol propionate—Skin disorder—Etoposide—testicular cancer	0.00361	0.00361	CcSEcCtD
Clobetasol propionate—Dry skin—Doxorubicin—testicular cancer	0.0036	0.0036	CcSEcCtD
Clobetasol propionate—Rash—Bleomycin—testicular cancer	0.00347	0.00347	CcSEcCtD
Clobetasol propionate—Pain—Cisplatin—testicular cancer	0.00347	0.00347	CcSEcCtD
Clobetasol propionate—Dermatitis—Bleomycin—testicular cancer	0.00347	0.00347	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Ifosfamide—testicular cancer	0.00347	0.00347	CcSEcCtD
Clobetasol propionate—Paraesthesia—Etoposide—testicular cancer	0.00334	0.00334	CcSEcCtD
Clobetasol propionate—Pruritus—Ifosfamide—testicular cancer	0.00333	0.00333	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Epirubicin—testicular cancer	0.00331	0.00331	CcSEcCtD
Clobetasol propionate—Rash—Dactinomycin—testicular cancer	0.00324	0.00324	CcSEcCtD
Clobetasol propionate—Pain—Etoposide—testicular cancer	0.00318	0.00318	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Doxorubicin—testicular cancer	0.00306	0.00306	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Cisplatin—testicular cancer	0.00299	0.00299	CcSEcCtD
Clobetasol propionate—Rash—Ifosfamide—testicular cancer	0.00297	0.00297	CcSEcCtD
Clobetasol propionate—Dermatitis—Ifosfamide—testicular cancer	0.00296	0.00296	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Epirubicin—testicular cancer	0.00292	0.00292	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Epirubicin—testicular cancer	0.00289	0.00289	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Epirubicin—testicular cancer	0.00288	0.00288	CcSEcCtD
Clobetasol propionate—Alopecia—Methotrexate—testicular cancer	0.00277	0.00277	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Etoposide—testicular cancer	0.00274	0.00274	CcSEcCtD
Clobetasol propionate—Erythema—Methotrexate—testicular cancer	0.00273	0.00273	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Doxorubicin—testicular cancer	0.0027	0.0027	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Doxorubicin—testicular cancer	0.00267	0.00267	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Doxorubicin—testicular cancer	0.00267	0.00267	CcSEcCtD
Clobetasol propionate—Pruritus—Etoposide—testicular cancer	0.00263	0.00263	CcSEcCtD
Clobetasol propionate—Alopecia—Epirubicin—testicular cancer	0.00259	0.00259	CcSEcCtD
Clobetasol propionate—Rash—Cisplatin—testicular cancer	0.00256	0.00256	CcSEcCtD
Clobetasol propionate—Dermatitis—Cisplatin—testicular cancer	0.00256	0.00256	CcSEcCtD
Clobetasol propionate—Erythema—Epirubicin—testicular cancer	0.00255	0.00255	CcSEcCtD
Clobetasol propionate—Alopecia—Doxorubicin—testicular cancer	0.0024	0.0024	CcSEcCtD
Clobetasol propionate—Erythema—Doxorubicin—testicular cancer	0.00236	0.00236	CcSEcCtD
Clobetasol propionate—Rash—Etoposide—testicular cancer	0.00234	0.00234	CcSEcCtD
Clobetasol propionate—Dermatitis—Etoposide—testicular cancer	0.00234	0.00234	CcSEcCtD
Clobetasol propionate—Headache—Etoposide—testicular cancer	0.00233	0.00233	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00231	0.00231	CcSEcCtD
Clobetasol propionate—Infection—Methotrexate—testicular cancer	0.00221	0.00221	CcSEcCtD
Clobetasol propionate—Skin disorder—Methotrexate—testicular cancer	0.00216	0.00216	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00216	0.00216	CcSEcCtD
Clobetasol propionate—Infection—Epirubicin—testicular cancer	0.00207	0.00207	CcSEcCtD
Clobetasol propionate—Skin disorder—Epirubicin—testicular cancer	0.00202	0.00202	CcSEcCtD
Clobetasol propionate—Paraesthesia—Methotrexate—testicular cancer	0.002	0.002	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.002	0.002	CcSEcCtD
Clobetasol propionate—Infection—Doxorubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Clobetasol propionate—Pain—Methotrexate—testicular cancer	0.0019	0.0019	CcSEcCtD
Clobetasol propionate—Skin disorder—Doxorubicin—testicular cancer	0.00187	0.00187	CcSEcCtD
Clobetasol propionate—Paraesthesia—Epirubicin—testicular cancer	0.00187	0.00187	CcSEcCtD
Clobetasol propionate—Pain—Epirubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Clobetasol propionate—Paraesthesia—Doxorubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Clobetasol propionate—Pain—Doxorubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Methotrexate—testicular cancer	0.00164	0.00164	CcSEcCtD
Clobetasol propionate—Pruritus—Methotrexate—testicular cancer	0.00158	0.00158	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Epirubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Clobetasol propionate—Pruritus—Epirubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Doxorubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Clobetasol propionate—Rash—Methotrexate—testicular cancer	0.0014	0.0014	CcSEcCtD
Clobetasol propionate—Dermatitis—Methotrexate—testicular cancer	0.0014	0.0014	CcSEcCtD
Clobetasol propionate—Headache—Methotrexate—testicular cancer	0.00139	0.00139	CcSEcCtD
Clobetasol propionate—Pruritus—Doxorubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Clobetasol propionate—Rash—Epirubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Clobetasol propionate—Dermatitis—Epirubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Clobetasol propionate—Headache—Epirubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Clobetasol propionate—Rash—Doxorubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Clobetasol propionate—Dermatitis—Doxorubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Clobetasol propionate—Headache—Doxorubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
